Braxia Scientific Corp Stock Price To Book
| BRAXF Stock | USD 0 0 33.33% |
Braxia Scientific Corp fundamentals help investors to digest information that contributes to Braxia Scientific's financial success or failures. It also enables traders to predict the movement of Braxia Pink Sheet. The fundamental analysis module provides a way to measure Braxia Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Braxia Scientific pink sheet.
Braxia |
Braxia Scientific Corp Company Price To Book Analysis
Braxia Scientific's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Braxia Scientific Price To Book | 0.91 X |
Most of Braxia Scientific's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Braxia Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Braxia Scientific Corp has a Price To Book of 0.9069 times. This is 96.47% lower than that of the Healthcare sector and 84.99% lower than that of the Biotechnology industry. The price to book for all United States stocks is 90.46% higher than that of the company.
Braxia Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Braxia Scientific's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Braxia Scientific could also be used in its relative valuation, which is a method of valuing Braxia Scientific by comparing valuation metrics of similar companies.Braxia Scientific is currently under evaluation in price to book category among its peers.
Braxia Fundamentals
| Return On Equity | -1.02 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (4.42) % | |||
| Current Valuation | 4.7 M | |||
| Shares Outstanding | 240.72 M | |||
| Shares Owned By Insiders | 11.48 % | |||
| Shares Owned By Institutions | 0.34 % | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 4.45 X | |||
| Revenue | 1.49 M | |||
| Gross Profit | 246.87 K | |||
| EBITDA | (6.91 M) | |||
| Net Income | (12.13 M) | |||
| Cash And Equivalents | 7.68 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 52.55 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.48 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (4.52 M) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 1.59 | |||
| Market Capitalization | 13.03 M | |||
| Total Asset | 11.63 M | |||
| Net Asset | 11.63 M |
About Braxia Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Braxia Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Braxia Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Braxia Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Braxia Pink Sheet
Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.